• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病中的脑血管意外:发病率及危险因素

Cerebrovascular accidents in sickle cell disease: rates and risk factors.

作者信息

Ohene-Frempong K, Weiner S J, Sleeper L A, Miller S T, Embury S, Moohr J W, Wethers D L, Pegelow C H, Gill F M

机构信息

The University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

出版信息

Blood. 1998 Jan 1;91(1):288-94.

PMID:9414296
Abstract

Cerebrovascular accident (CVA) is a major complication of sickle cell disease. The incidence and mortality of and risk factors for CVA in sickle cell disease patients in the United States have been reported only in small patient samples. The Cooperative Study of Sickle Cell Disease collected clinical data on 4,082 sickle cell disease patients enrolled from 1978 to 1988. Patients were followed for an average of 5.2 +/- 2.0 years. Age-specific prevalence and incidence rates of CVA in patients with the common genotypes of sickle cell disease were determined, and the effects of hematologic and clinical events on the risk of CVA were analyzed. The highest rates of prevalence of CVA (4.01%) and incidence (0.61 per 100 patient-years) were in sickle cell anemia (SS) patients, but CVA occurred in all common genotypes. The incidence of infarctive CVA was lowest in SS patients 20 to 29 years of age and higher in children and older patients. Conversely, the incidence of hemorrhagic stroke in SS patients was highest among patients aged 20 to 29 years. Across all ages the mortality rate was 26% in the 2 weeks after hemorrhagic stroke. No deaths occurred after infarctive stroke. Risk factors for infarctive stroke included prior transient ischemic attack, low steady-state hemoglobin concentration and rate of and recent episode of acute chest syndrome, and elevated systolic blood pressure. Hemorrhagic stroke was associated with low steady-state hemoglobin and high leukocyte count.

摘要

脑血管意外(CVA)是镰状细胞病的主要并发症。美国镰状细胞病患者中CVA的发病率、死亡率及危险因素仅在小样本患者中有所报道。镰状细胞病合作研究收集了1978年至1988年登记的4082例镰状细胞病患者的临床数据。患者平均随访5.2±2.0年。确定了镰状细胞病常见基因型患者中CVA的年龄特异性患病率和发病率,并分析了血液学和临床事件对CVA风险的影响。CVA患病率最高(4.01%)和发病率最高(每100患者年0.61例)的是镰状细胞贫血(SS)患者,但所有常见基因型患者均会发生CVA。梗死性CVA的发病率在20至29岁的SS患者中最低,在儿童和老年患者中较高。相反,SS患者出血性中风的发病率在20至29岁患者中最高。在所有年龄段,出血性中风后2周内的死亡率为26%。梗死性中风后无死亡病例。梗死性中风的危险因素包括既往短暂性脑缺血发作、低稳态血红蛋白浓度及急性胸综合征的发生率和近期发作,以及收缩压升高。出血性中风与低稳态血红蛋白和高白细胞计数有关。

相似文献

1
Cerebrovascular accidents in sickle cell disease: rates and risk factors.镰状细胞病中的脑血管意外:发病率及危险因素
Blood. 1998 Jan 1;91(1):288-94.
2
The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.镰状细胞病中的急性胸综合征:发病率及危险因素。镰状细胞病合作研究。
Blood. 1994 Jul 15;84(2):643-9.
3
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.镰状细胞病患儿队列中第一个十年的临床事件。镰状细胞病合作研究。
Blood. 1995 Jul 15;86(2):776-83.
4
Molecular characteristics of pediatric patients with sickle cell anemia and stroke.镰状细胞贫血和中风患儿的分子特征
Am J Hematol. 2001 Jul;67(3):179-82. doi: 10.1002/ajh.1103.
5
Alpha thalassemia and stroke risk in sickle cell anemia.镰状细胞贫血中的α地中海贫血与中风风险
Am J Hematol. 1994 Apr;45(4):279-82. doi: 10.1002/ajh.2830450402.
6
Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease.镰状细胞病中的脑血管意外。危险因素及输血影响。法国镰状细胞病研究小组
Eur J Pediatr. 1993 Mar;152(3):201-4. doi: 10.1007/BF01956144.
7
Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. The SPRINT Study Group.急性心肌梗死并发脑血管意外:发病率、临床意义及短期和长期死亡率。SPRINT研究组
Am J Med. 1991 Jul;91(1):45-50. doi: 10.1016/0002-9343(91)90072-6.
8
Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.镰状细胞病患者从出生到5岁的参考值及血液学变化。镰状细胞病合作研究。
Arch Pediatr Adolesc Med. 1994 Aug;148(8):796-804. doi: 10.1001/archpedi.1994.02170080026005.
9
Stroke in a cohort of patients with homozygous sickle cell disease.一组纯合子镰状细胞病患者的中风情况。
J Pediatr. 1992 Mar;120(3):360-6. doi: 10.1016/s0022-3476(05)80897-2.
10
Stroke prevention and treatment in sickle cell disease.镰状细胞病的中风预防与治疗
Arch Neurol. 2001 Apr;58(4):565-8. doi: 10.1001/archneur.58.4.565.

引用本文的文献

1
Using updated clinical recommendations to support contraceptive decision-making: U.S. medical eligibility criteria for contraceptive use, 2024.利用最新临床建议支持避孕决策:2024年美国避孕使用医学资格标准
Contraception. 2025 Jul 14:111015. doi: 10.1016/j.contraception.2025.111015.
2
Causes and clinical presentation of stroke in children in Cameroon.喀麦隆儿童中风的病因及临床表现
Ghana Med J. 2025 Mar;59(1):10-14. doi: 10.4314/gmj.v59i1.2.
3
Primary Stroke Screening and Hydroxyurea Treatment for Sickle Cell Anemia in Pediatric Healthcare Settings in East and Central Africa: A Narrative Review of Capacity Gaps and Opportunities.
东非和中非儿科医疗环境中镰状细胞贫血的初级卒中筛查与羟基脲治疗:能力差距与机遇的叙述性综述
Public Health Rev. 2025 May 15;46:1608359. doi: 10.3389/phrs.2025.1608359. eCollection 2025.
4
The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape.镰状细胞病的表型:在意大利环境中帮助识别未确诊患者的策略。
Ital J Pediatr. 2025 May 28;51(1):157. doi: 10.1186/s13052-025-01992-y.
5
Dynamics of neutrophil phenotype and function in sickle cell disease.镰状细胞病中性粒细胞表型与功能的动态变化
Front Immunol. 2025 May 2;16:1591283. doi: 10.3389/fimmu.2025.1591283. eCollection 2025.
6
Prevalence of Antiplatelet and Anticoagulation Therapy in Children with Sickle Cell Anemia and Stroke.镰状细胞贫血和中风患儿中抗血小板和抗凝治疗的患病率。
Pediatr Stroke. 2025;11:111-140.
7
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks.在乌干达羟基脲试验中,尽管小儿镰状细胞贫血患者的经颅多普勒速度总体有所改善,但仍有卒中事件发生:既往及持续存在的风险。
Pediatr Blood Cancer. 2025 Jul;72(7):e31722. doi: 10.1002/pbc.31722. Epub 2025 Apr 22.
8
Assessment of Inter-Reader Reliability of Fazekas Scoring on Magnetic Resonance Imaging of the Brain in Adult Patients with Sickle Cell Disease.镰状细胞病成年患者脑部磁共振成像中 Fazekas 评分的阅片者间可靠性评估
Diagnostics (Basel). 2025 Mar 27;15(7):857. doi: 10.3390/diagnostics15070857.
9
Sticking together: Polymerization of sickle hemoglobin drives the multiscale pathophysiology of sickle cell disease.凝聚在一起:镰状血红蛋白的聚合驱动镰状细胞病的多尺度病理生理学。
Biophys Rev (Melville). 2025 Mar 20;6(1):011309. doi: 10.1063/5.0238698. eCollection 2025 Mar.
10
Paediatric cerebrovascular syndromes: imaging clues to a diagnosis.小儿脑血管综合征:诊断的影像学线索
Br J Radiol. 2025 Jun 1;98(1170):875-889. doi: 10.1093/bjr/tqaf057.